Outcome Measures Primary The primary outcome measures are the changes from baseline in metabolomic profiling 1 month after nephrectomy or after antiangiogenic treatment during 2 months Cohort 1. The primary clinical outcome measure is progression-free survival (PFS), the interval from first line therapy to first evidence of progression disease or death from RCC.